Singular Health Group Ltd has released a press release.
Enterprise Licence Order Received for 3Dicom R&D Software
Filed with ASX ·
6ix hasn’t read this filing yet.
Singular Health Group Ltd on 6ix
Earlier from Singular Health
- Singular Receives Commitment for $850,000 from CG1 Ventures
- Singular Receives R&D Tax Incentive Refund
- Appointment of Managing Director and Chief Executive Officer
- Preliminary Final Report
- Strategic Investment from Master Distributor in USA
Later from Singular Health
- First 3Dicom Enterprise Sale Received in United States
- First Enterprise Sale in United States Medical Education
- CG1 Ventures Placement & R&D Advanced Funding
- Capital Raising
- Singular Retains ISO13485.2016 Certification
Follow Singular Health into a list and get an email when it puts out news.
Follow Singular Health